BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Human chorionic gonadotropin
,
Aspirin
,
rs3825942
,
PBX1
,
cell-cell adhesion
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MEC 4
Summary
General Info
Curated Studies
Most Correlated Studies
Leukemia MEC-1 and JVM-2 cells with gene overexpression of UGT2B17
Comparison of different cell subpopulations of the normal human breast
Dorsal and ventral medial entorhinal cortices of 8wk old C57BL/6JolaHsd male mice
Deaf-1 regulated genes in the mouse mammary gland
Regulatory T cells derived from embryonic or adult hematopoeitic stem cells
Explore Curated Studies Results
Literature
Most Relevant Literature
Pore-lining residues of MEC-4 and MEC-10 channel subunits tune the Caenorhabditis elegans degenerin …
Regulation of mechanosensation in C. elegans through ubiquitination of the MEC-4 mechanotransduction…
Progressive recruitment of distal MEC-4 channels determines touch response strength in C. elegans.
Ultrasound Activation of Mechanosensory Ion Channels in Caenorhabditis Elegans.
Two pathways are required for ultrasound-evoked behavioral changes in Caenorhabditis elegans.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Sirolimus in Combination With MEC in High Risk Myeloid Leukemias
Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nau…
Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Mye…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ